Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 15, 2023

Primary Completion Date

July 1, 2024

Study Completion Date

September 1, 2024

Conditions
Endometrial Cancer
Interventions
DRUG

Gallium-68-tilmanocept

All participants receive a cervical injection with 10 MBq 68Ga-tilmanocept in an outpatient setting (at least one week) before surgery. Within 30-90 minutes post-injection a PET with contrast enhanced CT is performed (PET/CT). Data (i.e. detection rate) from the imaging modalities are collected.

Trial Locations (1)

3584CX

RECRUITING

Cornelis G Gerestein, Utrecht

All Listed Sponsors
lead

UMC Utrecht

OTHER